Polarean Imaging PLC - medical imaging products developer - Completes installation of research unit order for a 9820 Xenon Polariser system at University of Kansas Medical Center. "We look forward to extending our working relationship with KU Medical Center as they launch their pulmonary research programmes, thereby expanding the clinical and public health frontiers of hyperpolarised xenon imaging to help clinicians and patients with lung diseases," Polaren Chief Executive Officer Richard Hullihen said.
Current stock price: 48.00 pence
Year-to-date change: up more than double from 22.00p
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
polarean (POLX)